Answers are grounded in this paper and cite their sources.
Background: Drug courts are a diversionary alternative for people with substance use disorders involved in the criminal legal system. Drug courts mandate and monitor substance use disorder treatment provided by community treatment agencies. Up to 80% of drug court clients have opioid use disorder (OUD), yet medications for OUD (MOUD), the gold standard treatment, are underutilized by drug court clients, partially due to limited collaborations between drug courts and local MOUD agencies. The Clinical Organization and Legal Organizations Alliance Building (COLAAB) intervention was designed to increase the number and quality of drug court-MOUD agency collaborations. COLAAB is a six-month intervention involving structured monthly meetings between court team members and local MOUD agency representatives, facilitation from an academic liaison, development of resource guides, and tours of drug courts and MOUD clinics. Design/Methods : We will evaluate COLAAB using a hybrid type II stepped-wedge cluster randomized controlled trial in 16 adult drug courts (8 in Massachusetts and 8 in Florida), with court team members and MOUD agency representatives as study participants. We will randomly assign courts to five clusters (1-2 courts per state per cluster) and initiate COLAAB in staggered six-month intervals. COLAAB implementation outcomes (COLAAB adoption, acceptability, appropriateness, feasibility, fidelity, cost) will be assessed using surveys, interviews, and observations. Organizational outcomes (e.g., number of collaborations, interorganizational collaboration quality, intention to refer) will be assessed using pre-post surveys and interviews. Finally, we will explore COLAAB’s effects on MOUD referrals and initiation using pre-post survey and administrative data. Conclusion: COLAAB could improve collaboration between courts and local MOUD agencies, thereby improving drug court client MOUD access. If COLAAB is proven effective, research findings will inform widespread dissemination of an implementation toolkit.
No takes yet. Share an insight, caveat, or question.
Andraka-Christou et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: